Basic Information
Aptinyx is an Evanston-based biopharmaceutical startup dedicated to discovering and developing innovative therapies for challenging brain and nervous system disorders. Aptinyx has a proven platform for discovering proprietary compounds that work through a novel mechanism: modulating NMDA receptors to enhance pathways related to nerve cell communication. These compounds are applicable to many central nervous system disorders.
Aptinyx, Inc.
Illinois,United States of America
51~100 people
January 01, 2015
corporate@aptinyx.com

